Cooper Companies (NYSE:COO) issued an update on its FY 2019 earnings guidance on Tuesday morning. The company provided EPS guidance of $11.85-12.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $11.57. The company issued revenue guidance of $2.631-2.676 billion, compared to the consensus revenue estimate of $2.64 billion.
Cooper Companies stock opened at $290.22 on Wednesday. Cooper Companies has a 52 week low of $216.47 and a 52 week high of $295.36. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.03 and a quick ratio of 1.16. The stock has a market cap of $14.44 billion, a P/E ratio of 25.24, a price-to-earnings-growth ratio of 2.30 and a beta of 0.88.
Cooper Companies (NYSE:COO) last posted its earnings results on Tuesday, March 5th. The medical device company reported $2.88 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.50 by $0.38. Cooper Companies had a return on equity of 17.70% and a net margin of 5.52%. As a group, equities research analysts predict that Cooper Companies will post 11.56 earnings per share for the current fiscal year.
Several equities analysts recently commented on COO shares. Oppenheimer set a $282.00 target price on Cooper Companies and gave the stock a hold rating in a research report on Friday, December 7th. Piper Jaffray Companies restated an overweight rating and set a $325.00 target price on shares of Cooper Companies in a research report on Wednesday. KeyCorp reduced their target price on Cooper Companies from $298.00 to $296.00 and set an overweight rating for the company in a research report on Friday, December 7th. Wells Fargo & Co increased their target price on Cooper Companies from $295.00 to $305.00 and gave the company an outperform rating in a report on Friday, December 7th. Finally, Jefferies Financial Group raised their price objective on Cooper Companies to $305.00 and gave the company a buy rating in a research report on Friday, December 7th. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and nine have given a buy rating to the company’s stock. Cooper Companies currently has an average rating of Buy and an average target price of $296.20.
In other Cooper Companies news, Director Allan E. Rubenstein bought 348 shares of the business’s stock in a transaction on Monday, December 10th. The shares were acquired at an average cost of $241.59 per share, for a total transaction of $84,073.32. Following the purchase, the director now owns 4,524 shares in the company, valued at approximately $1,092,953.16. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 1.70% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Cooper Companies (COO) Updates FY 2019 Earnings Guidance” was reported by Ticker Report and is owned by of Ticker Report. If you are reading this news story on another publication, it was copied illegally and republished in violation of international copyright law. The original version of this news story can be viewed at https://www.tickerreport.com/banking-finance/4200779/cooper-companies-coo-updates-fy-2019-earnings-guidance.html.
Cooper Companies Company Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
See Also: The Structure of a Futures Contract
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.